FOLLOW HEART TRANSPLANT FOR ACHIEVING THE HEART PRIMITIVE RELATED SCLERODERMA SYSTEMIC

NCT ID: NCT02808481

Last Updated: 2016-06-21

Basic Information

• Recruitment Status: UNKNOWN
• Total Enrollment: 9 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2016-06-30
• Study Completion Date: 2016-12-31

Brief Summary

Systemic sclerosis is a rare disease. The early cardiac disease affects 10% of patients sclérodemiques.

Heart transplantation in the early cardiac involvement in systemic sclerosis is exceptional.

we see patient data analysis with systemic sclerosis who used cardiac transplantation to understand the primitive cardiac damage associated with systemic sclerosis

Conditions

Systemic Sclerosis

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: RETROSPECTIVE

Eligibility Criteria

Inclusion Criteria

• Adult patients meet the criteria for classification of systemic sclerosis
• Adverse primitive heart that required a heart transplant
• Patients who have given their verbal agreement to use their data for research purposes.

Exclusion Criteria

• Localized Scleroderma or sclerodermiform syndrome
• Heart disease secondary to pulmonary or renal impairment
• Refusal to participate in the study

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

University Hospital, Strasbourg, France

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Central Contacts

Emmanuel CHATELUS, MD

Role: CONTACT

emmanuel.chatelus@chru-strasbourg.fr

33 (0)3.88.12.81.15

Other Identifiers

6410

Identifier Type: -

Identifier Source: org_study_id